Cravatex

Mumbai, India Founded: 1951 • Age: 75 yrs Listed
International brands are franchised, licensed, and distributed globally by Cravatex.

About Cravatex

Cravatex is a publicly listed company based in Mumbai (India) founded in 1951. International brands are franchised, licensed, and distributed globally by Cravatex. The company has 8 employees. Its Indian entity Cravatex Limited reported revenue of β‚Ή168 Cr. Its focus areas include Consumer Goods, Retail Chains, Sporting & Outdoor Goods and Multi-Category.

Company details

Cravatex was founded in 1951 and operates as a retail, brand licensing, distribution, and sourcing company. Presence is maintained across the Indian Subcontinent, United Kingdom, Europe, North Africa, and the Middle East. Licenses for brands such as Fila are held in India and select other regions, supporting retail and distribution activities in the apparel and consumer goods sector.

  • Headquarters Mumbai, India
  • Employees 8
  • Stage Public
  • Sectors
    Retail
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cravatex.com
  • Social LinkedIn
  • Legal Name Cravatex Limited
Operational Areas
Key Metrics
  • Market Cap
    ₹84.16 Cr

    CRAVATEX · NSE

  • Share Price
    ₹337.50

    +3.46% today

  • Revenue
    ₹151 Cr

    FY 2025-26 · -13.2% YoY

  • EBITDA
    −₹6.37 Cr

    Margin -4.2%

  • Net Profit
    ₹6.72 Cr

    FY 2025-26 · +40.0% YoY

  • P/E (TTM)
    11.1x

    P/B 0.7x

  • ROE
    6.0%

    ROCE 7.7%

  • Latest Funding Round
    $11.46M (USD), Post-IPO

    Mar 2017

  • Investors
  • Employee Count
    8

Funding Insights of Cravatex

  • Total Rounds 1
  • Last Round Post-IPO β€” $11.46M
  • First Round $11.46M

    (Mar 2017)

  • Investors Count 1

All 1 funding rounds of Cravatex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2017$11.46MPost-IPO––
Valuation history

1 investors in total: 1 institutional.

Investors in Cravatex

Cravatex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Paragon Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
A leading Indian mid-market private equity firm is operated.
2015paragonpartners.inMumbai, India
Premium access

Investor details for Cravatex

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Cravatex Limited (Cravatex)

Cravatex Limited is the primary company behind Cravatex. The board of Cravatex Limited currently have 7 directors; the longest-serving is Rajesh Kumar Batra, appointed in 1981. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Kumar Batra
DIN 00020764
Managing Director30 Nov 198144 yrs 11 moCravatex Limited
Pheroza Jimmy Bilimoria
DIN 00191386
Director16 Sep 201412 yrs 2 moCravatex Limited
Rohan Kumar Batra
DIN 02574195
Director01 Apr 20206 yrs 7 moCravatex Limited
Divakar Ganapati Kamath
DIN 08730430
Director01 Apr 20206 yrs 7 moCravatex Limited
Satyan Shivkumar Israni
DIN 01174081
Director12 Feb 20242 yrs 9 moCravatex Limited
Nakul Toshniwal
DIN 00350112
Director15 Feb 20242 yrs 9 moCravatex Limited
Rina Suresh Deora
DIN 00774812
Director20 May 20251 yr 5 moCravatex Limited

People of Cravatex

1 people are tracked at Cravatex (1 in leadership); the tracked headcount is 8.

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Cravatex

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Cravatex

Cravatex is a publicly listed company on the BSE with ticker symbol CRAVATEX in India, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Mar 1980
  • Listed onBSE: 509472
  • Listed entityCravatex Limited
  • Exchange sectorRetail trade
  • ISININE145E01017
  • Share price₹354.00 · 2026-05-11
  • Market capitalisation₹91.5 Cr
  • Price to earnings13.8
  • EPS (diluted, trailing year)₹25.69
  • Dividend yield3.53%
  • Volume (last session)378
  • Analyst consensusNo rating

Financials of Cravatex

Exchange-reported figures of Cravatex Limited, the listed company behind Cravatex (NSE: CRAVATEX).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹151 Cr
-13.2% YoY
EBITDA
−₹6.37 Cr
-279.2% YoY
Profit After Tax
₹6.72 Cr
+40.0% YoY
Net Worth
₹119 Cr
+12.2% YoY
Total Assets
₹122 Cr
+11.0% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue151174203504594532865
Revenue growth-13.2%-14.3%-59.8%-15.3%+11.7%-38.5%-
EBITDA(6.37)(1.68)(7.65)(29.89)2.05(11.88)21.25
EBITDA margin-4.2%-1.0%-3.8%-5.9%+0.3%-2.2%+2.5%
Profit before tax8.586.386.1658.34(18.56)(29.75)(2.41)
Net profit6.724.804.81(45.14)(20.04)(30.13)(4.71)
Net profit margin+4.5%+2.8%+2.4%-9.0%-3.4%-5.7%-0.5%
EPS (β‚Ή)26.3018.6818.68228.05(76.95)(118.45)(18.24)
Balance sheet
Total assets12211010294.02219238282
Net worth11910698.7292.3629.8655.7863.16
Total debt0.000.000.000.0087.5170.59138
Cash & bank76.6275.4576.0556.3237.9736.0749.32
Net working capital94.3384.3684.5878.70145141157
Cash flow
Cash from operations1.272.9919.06144(7.56)(3.82)32.02
Cash from investing3.29(0.64)(1.32)42.4213.9320.55(37.33)
Cash from financing(3.23)(0.78)(0.39)(168)(3.69)(20.71)37.43
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue53.4632.2239.5136.7951.4523.1360.5232.43
Revenue growth (YoY)+3.9%+39.3%-34.7%+13.4%-6.5%-10.3%--
Other income3.374.403.304.523.805.212.092.24
EBITDA3.05(3.28)(0.60)(2.44)2.76(6.10)0.50(1.87)
EBITDA margin+5.7%-10.2%-1.5%-6.6%+5.4%-26.4%+0.8%-5.8%
Depreciation0.380.380.370.380.380.380.400.40
Interest0.080.080.090.090.090.090.090.11
Profit before tax5.960.662.241.616.09(1.36)2.10(0.14)
Tax1.350.230.640.270.870.010.67(0.39)
Net profit4.610.431.601.345.22(1.37)1.430.25
EPS (β‚Ή)17.881.706.195.2120.18(5.29)5.590.97
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue7.104.801.873.482.442.312.42
Revenue growth+47.9%+156.7%-46.3%+42.6%+5.6%-4.6%-
EBITDA(2.33)(2.67)(2.28)(35.49)(2.23)(2.43)(2.90)
EBITDA margin-32.8%-55.6%-121.9%-1019.8%-91.4%-105.2%-119.8%
Profit before tax5.745.403.36(27.79)5.096.192.55
Net profit5.454.833.535.014.345.862.31
Net profit margin+76.8%+100.6%+188.8%+144.0%+177.9%+253.7%+95.5%
EPS (β‚Ή)21.4818.8213.69(105.03)16.9822.318.98
Balance sheet
Total assets26.0624.6920.7415.9250.1448.0140.69
Net worth23.8021.5017.4514.2646.2042.5536.96
Total debt0.000.000.000.000.000.000.10
Cash & bank0.250.383.243.430.930.570.21
Net working capital(0.67)0.312.860.51(1.78)(0.73)(2.09)
Cash flow
Cash from operations(2.50)(3.39)(2.46)(5.18)(3.23)(2.02)(2.04)
Cash from investing5.763.460.2916.055.273.635.12
Cash from financing(3.23)(0.78)(0.39)(8.36)(1.67)(1.23)(3.77)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1.471.440.003.132.531.440.002.54
Revenue growth (YoY)-41.9%0.0%-+23.2%+12.0%---
Other income1.411.403.143.631.261.351.443.40
Total expenses2.122.050.573.743.122.020.913.15
EBITDA(0.65)(0.61)(0.57)(0.61)(0.59)(0.58)(0.91)(0.61)
EBITDA margin-44.2%-42.4%--19.5%-23.3%-40.3%--24.0%
Depreciation0.240.230.240.240.240.230.260.26
Interest0.080.080.080.090.090.090.090.11
Profit before tax0.440.482.252.690.340.450.182.42
Tax(0.01)0.060.110.070.010.010.16(0.04)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 17 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue53.4632.2239.5136.7951.4523.1360.5232.43
Revenue growth (YoY)+3.9%+39.3%-34.7%+13.4%-6.5%-10.3%--
Other income3.374.403.304.523.805.212.092.24
EBITDA3.05(3.28)(0.60)(2.44)2.76(6.10)0.50(1.87)
EBITDA margin+5.7%-10.2%-1.5%-6.6%+5.4%-26.4%+0.8%-5.8%
Depreciation0.380.380.370.380.380.380.400.40
Interest0.080.080.090.090.090.090.090.11
Profit before tax5.960.662.241.616.09(1.36)2.10(0.14)
Tax1.350.230.640.270.870.010.67(0.39)
Net profit4.610.431.601.345.22(1.37)1.430.25
EPS (β‚Ή)17.881.706.195.2120.18(5.29)5.590.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue151174203504594532865
Revenue growth-13.2%-14.3%-59.8%-15.3%+11.7%-38.5%-
Other income16.829.9516.101189.9314.315.26
Total expenses157175210534592544843
Employee cost32.4427.0828.9360.7264.7264.1670.99
EBITDA(6.37)(1.68)(7.65)(29.89)2.05(11.88)21.25
EBITDA margin-4.2%-1.0%-3.8%-5.9%+0.3%-2.2%+2.5%
Depreciation1.511.481.8816.1416.3717.4414.98
Interest0.360.410.4113.8114.1714.7413.94
Profit before tax8.586.386.1658.34(18.56)(29.75)(2.41)
Tax1.781.551.33(0.60)1.340.852.29
Net profit6.724.804.81(45.14)(20.04)(30.13)(4.71)
Net profit margin+4.5%+2.8%+2.4%-9.0%-3.4%-5.7%-0.5%
EPS (β‚Ή)26.3018.6818.68228.05(76.95)(118.45)(18.24)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital2.582.582.582.5882.2186.6566.77
Reserves & surplus11710496.1489.78(52.35)(30.87)(3.61)
Shareholders' funds (net worth)11910698.7292.3629.8655.7863.16
Minority interest0.000.000.000.0075.2475.2471.09
Secured loans0.000.000.000.0072.5170.5977.42
Unsecured loans0.000.000.000.0015.000.0060.31
Total debt0.000.000.000.0087.5170.59138
Total liabilities12211010294.02219238282
Assets
Gross block22.5622.5322.9421.94103110123
Net block8.348.998.788.0961.5376.4692.14
Capital work in progress0.000.000.000.000.000.000.00
Investments18.7215.898.094.624.6014.7924.56
Inventories23.0111.4810.6729.0494.3485.0081.61
Sundry debtors16.3323.9613.8526.21133143169
Cash & bank balances76.6275.4576.0556.3237.9736.0749.32
Loans & advances2.824.566.539.7724.5123.0415.85
Total current assets119115107121290287316
Total current liabilities24.4531.0922.5242.64145146159
Net working capital94.3384.3684.5878.70145141157
Total assets12211010294.02219238282
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash75.2173.6456.2937.9235.2539.237.11
Net cash from operating activities1.272.9919.06144(7.56)(3.82)32.02
Net cash from investing activities3.29(0.64)(1.32)42.4213.9320.55(37.33)
Net cash from financing activities(3.23)(0.78)(0.39)(168)(3.69)(20.71)37.43
Net change in cash1.331.5717.3518.362.68(3.98)32.12
Closing cash76.6275.4576.0556.3237.9736.0749.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-13.2%-14.3%-59.8%-15.3%+11.7%-38.5%-
EBITDA growth-279.2%+78.0%+74.4%-1558.1%+117.3%-155.9%-
PBT growth+34.5%+3.6%-89.4%+9998.0%+37.6%-1134.4%-
Net income growth+40.0%-0.2%+110.7%-125.3%+33.5%-539.7%-
Revenue CAGR (3Y)-33.1%-33.6%-27.5%-16.5%-6.1%+14.3%+48.1%
EBITDA CAGR (3Y)-40.3%--13.7%--56.0%+28.4%-
Profitability & leverage
Net income margin+4.5%+2.8%+2.4%+11.7%-3.4%-5.8%-0.5%
Return on capital employed+7.7%+6.4%+6.7%-28.9%0.0%0.0%+6.5%
Return on net worth+6.0%+4.7%+5.1%-212.0%0.0%0.0%-50.3%
Debt / equity0.000.000.000.721.851.751.28
Long-term debt / equity0.000.000.000.220.310.450.49
Interest cover-4.57-12.97-4.30-30.00-98.95-50.27222.33
Efficiency & per share
Fixed asset turnover6.697.649.038.035.574.569.16
Inventory turnover8.7515.6910.218.166.636.3810.46
Debtors turnover7.499.1910.126.324.303.405.41
EPS (β‚Ή)26.3018.6818.68228.05(76.95)(118.45)(18.24)
Dividend per share (β‚Ή)13.0012.503.001.503.003.003.00
Book value per share (β‚Ή)462.18411.83382.02357.42(192.58)(109.44)(3.96)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1.471.440.003.132.531.440.002.54
Revenue growth (YoY)-41.9%0.0%-+23.2%+12.0%---
Other income1.411.403.143.631.261.351.443.40
Total expenses2.122.050.573.743.122.020.913.15
EBITDA(0.65)(0.61)(0.57)(0.61)(0.59)(0.58)(0.91)(0.61)
EBITDA margin-44.2%-42.4%--19.5%-23.3%-40.3%--24.0%
Depreciation0.240.230.240.240.240.230.260.26
Interest0.080.080.080.090.090.090.090.11
Profit before tax0.440.482.252.690.340.450.182.42
Tax(0.01)0.060.110.070.010.010.16(0.04)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue7.104.801.873.482.442.312.42
Revenue growth+47.9%+156.7%-46.3%+42.6%+5.6%-4.6%-
Other income9.389.537.399.898.7610.027.11
Total expenses9.437.474.1538.974.674.745.32
Employee cost1.571.481.301.471.220.941.15
EBITDA(2.33)(2.67)(2.28)(35.49)(2.23)(2.43)(2.90)
EBITDA margin-32.8%-55.6%-121.9%-1019.8%-91.4%-105.2%-119.8%
Depreciation0.951.051.340.810.700.740.85
Interest0.360.410.411.380.740.660.81
Profit before tax5.745.403.36(27.79)5.096.192.55
Tax0.190.53(0.19)(0.64)0.710.420.24
Net profit5.454.833.535.014.345.862.31
Net profit margin+76.8%+100.6%+188.8%+144.0%+177.9%+253.7%+95.5%
EPS (β‚Ή)21.4818.8213.69(105.03)16.9822.318.98
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital2.582.582.582.586.616.576.47
Reserves & surplus21.2218.9214.8711.6839.5935.9830.49
Shareholders' funds (net worth)23.8021.5017.4514.2646.2042.5536.96
Secured loans0.000.000.000.000.000.000.10
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.000.000.000.000.000.10
Total liabilities26.0624.6920.7415.9250.1448.0140.69
Assets
Gross block12.0312.1914.6613.5014.2514.4916.21
Net block6.817.308.427.397.738.428.32
Capital work in progress0.000.000.000.000.000.000.00
Investments19.1416.318.515.0443.1340.3535.10
Inventories0.000.000.000.000.000.010.01
Sundry debtors0.000.010.020.120.010.150.63
Cash & bank balances0.250.383.243.430.930.570.21
Loans & advances0.941.351.270.870.620.870.92
Total current assets1.191.744.534.421.561.601.77
Total current liabilities1.861.431.673.913.342.333.86
Net working capital(0.67)0.312.860.51(1.78)(0.73)(2.09)
Total assets26.0624.6920.7415.9250.1448.0140.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.140.843.390.890.520.140.83
Net cash from operating activities(2.50)(3.39)(2.46)(5.18)(3.23)(2.02)(2.04)
Net cash from investing activities5.763.460.2916.055.273.635.12
Net cash from financing activities(3.23)(0.78)(0.39)(8.36)(1.67)(1.23)(3.77)
Net change in cash0.03(0.70)(2.56)2.510.370.38(0.70)
Closing cash0.250.383.243.430.930.570.21
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+47.9%+156.7%-46.3%+42.6%+5.6%-4.6%-
EBITDA growth+12.7%-17.1%+93.6%-1491.5%+8.2%+16.2%-
PBT growth+6.3%+60.7%+9998.0%--17.8%+142.8%-13.6%
Net income growth+12.8%+36.8%-29.5%+15.4%-25.9%+153.7%-
Revenue CAGR (3Y)+26.8%+25.3%-6.8%+12.9%+32.9%+46.2%-75.1%
EBITDA CAGR (3Y)-59.7%+6.2%-2.1%+130.5%-0.3%-3.2%+12.8%
Profitability & leverage
Net income margin+78.2%+101.5%+189.8%-780.2%+179.5%+249.8%+95.5%
Return on capital employed+24.0%+25.5%+20.6%0.0%+11.9%+15.5%+8.2%
Return on net worth+24.5%+25.0%+22.3%0.0%+10.9%+16.1%+7.2%
Debt / equity0.000.000.000.000.000.000.02
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-10.98-11.02-11.33-3.80-25.26-20.82-21.60
Efficiency & per share
Fixed asset turnover0.590.360.130.250.170.150.15
Inventory turnover0.000.000.000.00488.00231.0096.80
Debtors turnover1,420.00320.0026.7153.5430.505.925.63
EPS (β‚Ή)21.4818.8213.69(105.03)16.9822.318.98
Dividend per share (β‚Ή)13.0012.503.001.503.003.003.00
Book value per share (β‚Ή)92.1283.2167.5355.20163.18149.23127.99

Timeline of Cravatex

3 dated milestones of Cravatex across 66 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cravatex is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $11.5M.

Web traffic of Cravatex

The website of Cravatex (cravatex.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▼ 2.8% vs previous month

Top companies in Retail Stores & Chains

2 companies that operate in the same segment as Cravatex (Retail Stores & Chains) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Online platform offering a wide range of baby, kids, and maternity products
2010Pune, Maharashtra, IndiaUSD 513.39 MUSD 911.07 M3,752
Multi-format offline retail is operated in India.
1997Mumbai, Maharashtra, IndiaUSD 3.41 BUSD 280.87 K32
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cravatex

Premium access

Complete news archive for Cravatex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cravatex

Cravatex was founded in 1951 and raised its 1st funding round 66 years after it was founded.

Cravatex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Cravatex has 8 employees.

The primary company behind Cravatex, Cravatex Limited, reported revenue of β‚Ή168 Cr for FY 2026, down 13% year on year.

Cravatex was founded in 1951 and operates as a retail, brand licensing, distribution, and sourcing company. Presence is maintained across the Indian Subcontinent, United Kingdom, Europe, North Africa, and the Middle East. Licenses for brands such as Fila are held in India and select other regions, supporting retail and distribution activities in the apparel and consumer goods sector.

Yes, Cravatex is publicly traded on BSE under the ticker symbol CRAVATEX.

Cravatex has 1 investor. Key investors include Paragon Partners.

Cravatex operates through Cravatex Limited.

The legal entities of Cravatex currently have 8 directors, including Rohan Kumar Batra, Divakar Ganapati Kamath, Pheroza Jimmy Bilimoria and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available